» Articles » PMID: 33193074

A Comprehensive Analysis of MicroRNAs in Human Osteoporosis

Overview
Specialty Endocrinology
Date 2020 Nov 16
PMID 33193074
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are single-stranded RNA molecules that control gene expression in various processes, such as cancers, Alzheimer's disease, and bone metabolic diseases. However, the regulatory roles of miRNAs in osteoporosis have not been systematically analyzed. Here, we performed a comprehensive analysis to identify the differentially expressed miRNAs involved in osteoporosis. MiRNAs associated with osteoporosis were collected through literature retrieval and further screened based on specific inclusion and exclusion criteria. The osteoporosis therapeutic targets of miRNAs were obtained by the integration of miRWalk 3.0 database and five human disease therapeutic target databases. Then, the network analysis and functional enrichment analysis of miRNAs and their targets were performed. As a result, 11 eligible miRNAs were identified highly associated with osteoporosis. MiRNA-mRNA network demonstrated there were the complex mutual interactions between miRNAs and their targets. Besides, ADRB2, AR, ESR1, FGFR1, TRAF6, etc., were identified as the top hub genes in protein-protein interaction (PPI) network. Functional enrichment analysis revealed that miRNAs and their targets were mainly mapped on processes associated with bone and immune system, such as bone remolding, bone mineralization, PI3K/AKt, TNF signaling pathways and Th17 cell differentiation. RT-PCR results showed that the expression of miR-335-3p was significantly down-regulated in hind limb unloading (HLU) mice tibia samples compared with controls, the remaining 10 miRNAs were significantly up-regulated after HLU ( < 0.01). In summary, we identified 11 differentially expressed miRNAs and their hub target genes in osteoporosis, which may be novel diagnostic biomarkers for osteoporosis.

Citing Articles

Psychological stress disturbs bone metabolism via miR-335-3p/Fos signaling in osteoclast.

Zhang J, Li J, Huang J, Xiang X, Li R, Zhai Y Elife. 2025; 13.

PMID: 39773351 PMC: 11709429. DOI: 10.7554/eLife.95944.


The DLEU2-miR-15a-16-1 Cluster Is a Determinant of Bone Microarchitecture and Strength in Postmenopausal Women and Mice.

Reppe S, Reseland J, Prijatelj V, Prediger M, Nogueira L, Utheim T Int J Mol Sci. 2024; 25(23).

PMID: 39684435 PMC: 11641114. DOI: 10.3390/ijms252312724.


MicroRNA binding site variants-new potential markers of primary osteoporosis in men and women.

Yalaev B, Deev R, Tyurin A, Salakhov R, Smirnov K, Eremkina A Front Genet. 2024; 15:1470310.

PMID: 39411371 PMC: 11473367. DOI: 10.3389/fgene.2024.1470310.


Diet as an epigenetic factor in inflammatory bowel disease.

Marangoni K, Dorneles G, da Silva D, Pinto L, Rossoni C, Fernandes S World J Gastroenterol. 2023; 29(41):5618-5629.

PMID: 38077158 PMC: 10701328. DOI: 10.3748/wjg.v29.i41.5618.


M2 macrophage-derived exosomal miR-486-5p influences the differentiation potential of bone marrow mesenchymal stem cells and osteoporosis.

Liu J, Sun Z, You Y, Zhang L, Hou D, Gu G Aging (Albany NY). 2023; 15(18):9499-9520.

PMID: 37751585 PMC: 10564417. DOI: 10.18632/aging.205031.


References
1.
Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y . Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006; 203(12):2673-82. PMC: 2118166. DOI: 10.1084/jem.20061775. View

2.
Weitzmann M . Bone and the Immune System. Toxicol Pathol. 2017; 45(7):911-924. PMC: 5749254. DOI: 10.1177/0192623317735316. View

3.
Gong Y, Xu F, Zhang L, Qian Y, Chen J, Huang H . MicroRNA expression signature for Satb2-induced osteogenic differentiation in bone marrow stromal cells. Mol Cell Biochem. 2013; 387(1-2):227-39. DOI: 10.1007/s11010-013-1888-z. View

4.
Huang Y, Shen X, Zou Q, Peng Wang S, Tang S, Zhang G . Biological functions of microRNAs: a review. J Physiol Biochem. 2010; 67(1):129-39. DOI: 10.1007/s13105-010-0050-6. View

5.
Sanchez-Riera L, Carnahan E, Vos T, Veerman L, Norman R, Lim S . The global burden attributable to low bone mineral density. Ann Rheum Dis. 2014; 73(9):1635-45. DOI: 10.1136/annrheumdis-2013-204320. View